Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium Health Condition 2: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: Liposomal iron – 29 mg elemental iron per tablet: Liposomal iron is a form of oral iron supplement where the iron is encapsulated within liposomes. This liposomal delivery system protec
Sponsors
Department of Pharmacology Institute of Post Graduate Medical Education And Research
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant women aged at least 18 years. Gestational age at least 14 weeks (second trimester). Diagnosed with iron deficiency anemia (Hb 7.0 to 10.5 g/dL with other parameters suggestive of iron deficiency) Willing to provide written informed consent and adhere to study.
Exclusion criteria
Exclusion criteria: Severe anemia (Hb less than 7 g/dL) Requirement of parenteral iron. History of hookworm infestation or chronic bleeding from any source. Known hemoglobinopathies (For example thalassemia, sickle cell anemia). Gastrointestinal disorders affecting iron absorption. History of allergy to oral iron supplements. Co-existing chronic illnesses (For example chronic kidney disease, malignancy, chronic liver disease) likely to affect response to oral iron therapy). Received parenteral iron therapy within last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase in hemoglobin by 2 gm/ dl after treatmentTimepoint: Participants will be followed up at 4, 8, and 12 weeks post enrolment | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in serum iron, total iron binding capacity, transferrin saturation. Changes in PCV, RBC indices (MCV, MCH, MCHC) and peripheral red cell morphology.Timepoint: Participants will be followed up at 12 weeks post enrolment | — |
Countries
India
Contacts
Public ContactDR AVIJIT HAZRA
IPGMER and SSKM Hospital
Outcome results
None listed